Horizon Finance (HRZN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
21 Aug, 2026Executive summary
Completed merger with Monroe Capital Corporation in April 2026, expanding equity capital by $141 million and incurring $4.4 million in non-recurring merger expenses; former MRCC stockholders now own 29.86% of the combined company.
Focused on secured debt investments in technology, life sciences, healthcare, and sustainability sectors, with a strategy to generate attractive risk-adjusted returns and capital appreciation via warrants.
Formed a $100 million joint venture, RoHo Capital, with Roth Capital Partners.
Actively building a robust pipeline of venture debt and small cap public company investments, with a committed backlog of $228 million.
Portfolio at June 30, 2026: $648 million in debt investments, $17 million in warrants, $4 million in other investments, $8 million in equity, and $0.2 million in RoHo JV.
Financial highlights
Debt investment portfolio grew for the third consecutive quarter, reaching $676.7 million with a 14.9% annualized yield as of June 30, 2026.
Total investment income for Q2 2026 was $25 million, up from $24.5 million year-over-year.
Net investment income for Q2 2026 was $7.4 million ($0.11 per share), down from $11.4 million ($0.28 per share) year-over-year, mainly due to merger costs.
Net asset value per share at June 30, 2026 was $6.23, down from $6.98 at December 31, 2025, impacted by unrealized losses on a single portfolio company.
Distributions declared per share were $0.27 for Q2 2026 and $0.45 for the six months ended June 30, 2026.
Outlook and guidance
Board declared regular and special monthly cash distributions for Q3 and Q4 2026; per share undistributed spillover income as of June 30, 2026 was $0.33.
Management expects to leverage a stronger balance sheet and robust pipeline to drive long-term value and portfolio growth, supported by $228 million committed backlog and $464 million available investment capacity.
Expectation to deliver NII at or above declared distributions over time as capital from the merger is deployed.
Management expects current cash, operations, and credit facilities to be sufficient for at least the next 12 months.
Latest events from Horizon Finance
- Annual meeting to elect directors and ratify new auditor, with strong governance focus.HRZN
Proxy filing - Merger added $141.1M, portfolio grew, and $0.27/share Q3 2026 distributions declared.HRZN
Q1 2026 - Supplemental distributions proposed to enhance shareholder value amid merger approval process.HRZN
Proxy Filing - Q4 portfolio growth, 14.3% yield, $647M assets, and merger set for future expansion.HRZN
Q4 2025 - Net investment income rose to $14M, with an 18.6% yield and $0.33/share distributions declared.HRZN
Q3 2025 - Merger creates a $446M NAV BDC, delivering a 33% NAV premium and scale benefits.HRZN
Q2 2025 - Net investment income fell, but portfolio growth and strong liquidity supported distributions.HRZN
Q3 2024 - Portfolio yield held at 15.9% as NII and NAV fell, with growth expected in H2 2024.HRZN
Q2 2024 - NII covered distributions in 2024, but NAV fell; strong yield and liquidity support 2025 growth.HRZN
Q4 2024